The relationship between the expression levels of microRNAs (miR-21, miR-221, miR-222, and miR-429) and morphometric parameters of the thymus was studied in female Wistar rats with breast cancer receiving and not receiving chemotherapy. In breast cancer, the following positive relationships were revealed: miR-221 in the subcapsular zone of the cortical substance with medium lymphocytes, miR-221 in the central part of the cortical substance with immunoblasts and macrophages, miR-429 in the subcapsular zone of the cortical substance with mitotically dividing cells, miR-429 in the central part of the medullary substance with macrophages, and miR-21 with medium lymphocytes of the thymus. In the subcapsular zone of the cortical substance, proliferative activity and the number of cells with pyknotic nuclei were increased. After chemotherapy, the relationship of microRNAs in the lymph with transformations in the thymus can indicate destructive processes in the breast tumor in comparison with breast cancer without treatment and indicate strengthening of the antitumor immunity, a decrease in the number of dying cells, and lymphoid depletion of the morphofunctional zones of the thymic parenchyma. Positive relationships of miR-21 with medium and small lymphocytes, miR-221 and miR-429 with epithelial cells, miR-222 with macrophages in the central part of the cortex, and miR-222 with macrophages in the central part of the medulla were found.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Breast cancer statistics, 2019. CA Cancer J. Clin. 2019;69(6):438-451. doi: https://doi.org/10.3322/caac.21583
Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122-1143. doi: https://doi.org/10.7150/thno.11543
Thapa P, Farber DL. The Role of the thymus in the immune response. Thorac. Surg. Clin. 2019;29(2):123-131. doi: https://doi.org/10.1016/j.thorsurg.2018.12.001
Kazakov OV, Poveshchenko AF, Kabakov AV, Poveshchenko OV, Strunkin DN, Lykov AP, Konenkov VI. Comparing the effects of surgical treatment and chemotherapy on the thymus structure in experimental breast cancer. Patol. Fiziol. Eksper. Ter. 2021;65(2):37-43. Russian. doi: https://doi.org/10.25557/0031-2991.2021.02.37-43
Cava C, Novello C, Martelli C, Lodico A, Ottobrini L, Piccotti F, Truffi M, Corsi F, Bertoli G, Castiglioni I. Theranostic application of miR-429 in HER2+ breast cancer. Theranostics. 2020;10(1):50-61. doi: https://doi.org/10.7150/thno.36274
Li J, Guan X, Fan Z, Ching LM, Li Y, Wang X, Cao WM, Liu DX. Non-invasive biomarkers for early detection of breast cancer. Cancers (Basel). 2020;12(10):2767. doi: https://doi.org/10.3390/cancers12102767
Matsuzaki J, Suzuki H. Role of MicroRNAs-221/222 in digestive systems. J. Clin. Med. 2015;4(8):1566-1577. doi: https://doi.org/10.3390/jcm4081566
Zhao D, Zhuang N, Ding Y, Kang Y, Shi L. MiR-221 activates the NF-κB pathway by targeting A20. Biochem. Biophys. Res. Commun. 2016;472(1):11-18. doi: https://doi.org/10.1016/j.bbrc.2015.11.009
Lappas M. A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes. Mol. Hum. Reprod. 2017;23(9):628-645. doi: https://doi.org/10.1093/molehr/gax041
Yang CH, Pfeffer SR, Sims M, Yue J, Wang Y, Linga VG, Paulus E, Davidoff AM, Pfeffer LM. The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis. J. Biol. Chem. 2015;290(10):6037-6046. doi: https://doi.org/10.1074/jbc.M114.632125
Han M, Wang F, Gu Y, Pei X, Guo G, Yu C, Li L, Zhu M, Xiong Y, Wang Y. MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways. Oncol. Rep. 2016;35(1):73-80. doi: https://doi.org/10.3892/or.2015.4360
Zhang L, Yan H, Wang H, Wang L, Bai B, Ma Y, Tie Y, Xi Z. MicroRNA (miR)-429 promotes inflammatory injury by targeting Kruppel-like factor 4 (KLF4) in neonatal pneumonia. Curr. Neurovasc. Res. 2020;17(1):102-109. doi: https://doi.org/10.2174/1567202617666200128143634
Lu Y, Zhao Q, Liao JY, Song E, Xia Q, Pan J, Li Y, Li J, Zhou B, Ye Y, Di C, Yu S, Zeng Y, Su S. Complement signals determine opposite effects of B cells in chemotherapy-induced immunity. Cell. 2020;180(6):1081-1097.e24. doi: https://doi.org/10.1016/j.cell.2020.02.015
Brockwell NK, Rautela J, Owen KL, Gearing LJ, Deb S, Harvey K, Spurling A, Zanker D, Chan CL, Cumming HE, Deng N, Zakhour JM, Duivenvoorden HM, Robinson T, Harris M, White M, Fox J, Ooi C, Kumar B, Thomson J, Potasz N, Swarbrick A, Hertzog PJ, Molloy TJ, Toole SO, Ganju V, Parker BS. Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC. NPJ Precis Oncol. 2019;3:21. doi: https://doi.org/10.1038/s41698-019-0093-2
Shi Y, Zhu M. Medullary thymic epithelial cells, the indispensable player in central tolerance. Sci. China Life Sci. 2013;56(5):392-398. doi: https://doi.org/10.1007/s11427-013-4482-4
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 175, No. 5, pp. 624-628, May, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kazakov, O.V., Poveshchenko, A.F. & Kabakov, A.V. Influence of Chemotherapy on the Relationship between MicroRNA Levels in the Lymph with Thymus Structure in Experimental Breast Cancer. Bull Exp Biol Med 175, 681–684 (2023). https://doi.org/10.1007/s10517-023-05925-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05925-9